- AU$37.28m
- AU$23.71m
- AU$6.84m
Australia's Pharmaxis slides on discounted placement
Brief: Pharmaxis Says A$7.2 Mln Being Raised In An Oversubscribed Placement
Investor Presentation
Proposed issue of securities - PXS
PRE_NR Ends: 10:31:46
Placement
Brief: Pharmaxis Seeks Trading Halt
Trading Halt
Australia's Pharmaxis soars on U.S. FDA nod for mid-stage study of cancer drug
Brief: Pharmaxis Ltd Says FDA Clears Pharmaxis Cancer Drug To Progress To Phase 2 Study In Liver Cancer
PRE_NR Ends: 08:58:00
FDA Clears PXS Cancer Drug for Phase 2 Liver Cancer Study
Notification regarding unquoted securities - PXS
Investor Presentation
Change of Director's Interest Notice
Results of Meeting
Constitution as amended 3 November
Notification regarding unquoted securities - PXS
CEO Presentation to 2021 AGM